These findings suggest that, forexample, in lung cancers characterized by FGFR1 gene amplification there is greatertumor complexity or heterogeneity within the amplicon that may modulate thedependency on the FGFR1 [43]. This evidence concerns the gene FGFR1 and lung cancer.